Slow channel calcium antagonists in the treatment of supraventricular tachycardia.
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001283:Atrioventricular Node / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004110:Diltiazem / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009543:Nifedipine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010480:Perhexiline / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011690:Purkinje Fibers / Q000187:drug effects; D012849:Sinoatrial Node / Q000187:drug effects; D014693:Ventricular Fibrillation / Q000188:drug therapy*; D014700:Verapamil / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D010480:Perhexiline